ACE and congenital rubella syndrome: The genetic predisposition of RAAS pathway activity (e.g., polymorphisms in the ACE gene or angiotensinogen) in CRS is an area of interest, though not yet fully elucidated; conceivably, patients with high baseline RAAS activity might be at greater risk of combined heart–kidney decline (Figure 5) [33].